Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00041392 · ClinicalTrials.gov registry record · Phase 2
Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery
A Phase 2 study of Cardiovascular Diseases and Heart Diseases, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 389
- Enrollment target
- 1
- Study location
NCT00041392 is a Phase 2 study of Cardiovascular Diseases and Heart Diseases that has completed, run by Duke University. The registered enrollment target is 389 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00041392, a Phase 2 study of Cardiovascular Diseases and Heart Diseases, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 389 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the effects of supplemental magnesium on the neurocognitive function of individuals undergoing coronary artery bypass graft (CABG) surgery.
Conditions Studied
Interventions
- DRUG Magnesium
- DRUG 0.9% saline
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 389 participants |
| Start Date | 2001-12 |
| Est. Completion | 2009-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00041392
The ClinicalTrials.gov registry entry for NCT00041392 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 389 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Magnesium is the first listed.
NCT00041392 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00041392 about?
NCT00041392 is a clinical study titled "Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery". The purpose of this study is to examine the effects of supplemental magnesium on the neurocognitive function of individuals undergoing coronary artery bypass graft (CABG) surgery.
What is the current status of trial NCT00041392?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 389 participants. The study started on 2001-12. Estimated completion is 2009-05.
What conditions does trial NCT00041392 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Diseases, Coronary Disease, Neurologic Manifestations.
What interventions are being tested in trial NCT00041392?
The interventions under investigation include: Magnesium (DRUG), 0.9% saline (DRUG).
Who is sponsoring clinical trial NCT00041392?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00041392 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
RECRUITING · Phase 2
-
Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
RECRUITING · Phase 2
-
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RECRUITING · Phase 2
-
Omega-3D: Omega-3 for Diet-Driven Health Disparities
RECRUITING · Phase 2
-
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
RECRUITING · Phase 2
-
Virtual Care Strategies to Improve Participation in Cardiac Rehabilitation Among Veterans
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.